Written question asked by Stephen Morgan (Labour) on Thursday, 14 April 2022, in the House of Commons. It was due for an answer on Wednesday, 20 April 2022. It was answered by Maria Caulfield (Conservative) on Monday, 25 April 2022 on behalf of the Department of Health and Social Care.
Long Covid and ME/CFS
- Question
-
To ask the Secretary of State for Health and Social Care, whether his Department has made a comparative assessment of the (a) symptoms of and (b) treatments for myalgic encephalomyelitis and long covid.
- Answer
-
No comparative assessment has been made. The National Institute for Health and Care Excellence currently recommends separate pathways for the assessment, treatment, and management of the long term effects of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
Secondary information
- Type
- Written question
- Reference
- 154338
- Session
- 2021-22
- Subjects
- ME/CFS Long covid
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-07 08:31:56 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/154338
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/154338
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/154338